|A leading pharmaceutical company serving the cause of health around the world, Sanofi is dedicated to our customers, our employees and even more importantly, to the people who rely daily on our medicines.
We are inspired to move ahead and live up to our Group’s commitment to set forth groundbreaking innovations to drive back disease.
|Westmont Pharmaceuticals, Inc. is the premiere ethical product division subsidiary of United Laboratories, Inc. (Unilab), mandated as a general healthcare division. The company lives by its vision as the most responsive partner committed to providing a wide range of best value healthcare solutions for the Filipino family.
Westmont’s product portfolio offers a wide array of healthcare product lines that include antibiotics, anti-hypertensive, anti-ulcer, antihistamine, analgesics/antipyretic, anti-asthma, anti-motility, multivitamins, cough/cold, oral rehydration salts, steroid and laxative which are well trusted by doctors and patients nationwide.
Westmont also offers innovative products like Siliphos under the brand name Liverprime. Liverprime is a complex of two potent liver protectants, Silybin and Phosphatidylcholine. It provides the benefits of these agents in one compound. By fusing them through the patented phytosome technology, bioavailability of silybin is signifantly increased, providing optimal liver protection.
|Biomedis, Inc., established in 1961, is a full division of United Laboratories, Inc, the biggest wholly Filipino-owned pharmaceutical company in Southeast Asia. It carries a general medicine portfolio with 17 brand lines: antibiotics, pain management products, anti-fibrinylitic, EPO , adult male uro-genital products, betahistine, anti-urolithiasis, and an anti-hemorrhoidal product.
Biomedis allocates a significant part of its resources for continuing medical and professional education programs, participates in scientific conventions and post graduate courses in support of and in partnership with key medical opinion leaders and industry experts.
|In December 20, 1995, the UROLOGY CENTER OF THE PHILIPPINES, INC. was formally registered with the Securities and Exchange Commission.
Our first venture on Extracorporeal Shock Wave Lithotripsy (ESWL), the non-surgical removal of stones, was finally blessed in May 6, 1996 at the Stone Unit of Manila Doctors Hospital. A year after, UCPI Ambulatory Care Center was born. And presently, Urology Center of the Philippines was granted a license to operate as secondary hospital last November 2011 by the Department of Health.
UCPI performs the fastest growing, non-surgical treatment for early stage prostate cancer called Brachytherapy, the permanent seed implantation. This state-of-the-art procedure is another first in the Philippines introduced by UCPI
|Scientific Biotech Specialties Inc. (SBSI) is a company focused in in-vitro diagnostics testing, the target market of which spans the whole Philippines. It has been dedicated to helping develop an excellent diagnostics healthcare system in the Philippines by relentlessly looking for affordable and most recent innovations in in-vitro diagnostics and introducing them in the country.
SBSI has been operating for about eighteen (18) years in the Philippine diagnostics market. It has been one of the leading local diagnostics companies at the helm of developing innovative diagnostics products for hospitals and free standing laboratories all over the Philippines in the fields of hematology, immunology and clinical chemistry.
ISMH All Rights Reserved